Performance

RAPP +1.60%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
RAPP	+6.67%	-14.07%	+1.60%	—	-57.14%	0.28	0.00%

Summary

RAPP at a glance

RAPP returned +1.60% over the past year. Its worst drop in that year was -57.14%, smaller than 15% of stocks on Redstone, and its Sharpe ratio of 0.28 beats 40% of stocks on Redstone. It pays no dividends.

Ranking

How RAPP ranks

Current Drawdown

-50.34%

Rolling Volatility

108.21%

Actions

Metrics

Risk Indicators

Alpha5.66%

Beta1.21x

Sharpe0.28

Sortino0.39

Omega1.05

Calmar0.03

Martin0.93

Profile

About RAPP

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.5B
Listed: Jun 2024
Employees: 84
Headquarters: Boston, MA
Website: rapportrx.com

Comparisons

RAPP: Rapport Therapeutics, Inc.

RAPP at a glance

How RAPP ranks

Current Drawdown

Rolling Volatility

About RAPP

Related comparisons